Leerink views the buyout by UnitedHealth (UNH) as a "significant positive" for the shareholders of Catamaran (CTRX). The firm does not expect additional bidders to emerge. It also believes Catamaran will retain Cigna (CI) and HealthSpring as a client given the long-term nature of the contract and Catamaran's expertise in Medicare.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here